Physician Wealth Advisors Inc. Takes $136,000 Position in The Sherwin-Williams Company (NYSE:SHW)

Physician Wealth Advisors Inc. bought a new position in shares of The Sherwin-Williams Company (NYSE:SHWFree Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 399 shares of the specialty chemicals company’s stock, valued at approximately $136,000.

A number of other large investors have also recently bought and sold shares of SHW. Midwest Capital Advisors LLC acquired a new stake in Sherwin-Williams during the 4th quarter worth about $26,000. Lee Danner & Bass Inc. acquired a new stake in Sherwin-Williams during the fourth quarter worth about $28,000. FSA Wealth Management LLC purchased a new position in Sherwin-Williams during the third quarter valued at approximately $32,000. Sierra Ocean LLC acquired a new position in Sherwin-Williams in the fourth quarter valued at approximately $36,000. Finally, True Wealth Design LLC boosted its position in Sherwin-Williams by 1,000.0% in the 3rd quarter. True Wealth Design LLC now owns 99 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 90 shares in the last quarter. Hedge funds and other institutional investors own 77.67% of the company’s stock.

Insider Buying and Selling at Sherwin-Williams

In other news, insider Colin M. Davie sold 2,799 shares of the firm’s stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $360.30, for a total transaction of $1,008,479.70. Following the completion of the sale, the insider now owns 5,365 shares in the company, valued at $1,933,009.50. This trade represents a 34.28 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.60% of the stock is currently owned by company insiders.

Sherwin-Williams Stock Performance

SHW opened at $339.77 on Monday. The firm has a market capitalization of $85.46 billion, a PE ratio of 32.21, a PEG ratio of 2.98 and a beta of 1.23. The company has a current ratio of 0.79, a quick ratio of 0.46 and a debt-to-equity ratio of 2.02. The Sherwin-Williams Company has a twelve month low of $282.09 and a twelve month high of $400.42. The firm’s 50-day moving average price is $353.59 and its 200 day moving average price is $363.80.

Sherwin-Williams (NYSE:SHWGet Free Report) last posted its quarterly earnings results on Thursday, January 30th. The specialty chemicals company reported $2.09 EPS for the quarter, beating the consensus estimate of $2.07 by $0.02. Sherwin-Williams had a return on equity of 74.50% and a net margin of 11.61%. During the same period in the previous year, the firm earned $1.81 earnings per share. As a group, sell-side analysts expect that The Sherwin-Williams Company will post 12 EPS for the current fiscal year.

Sherwin-Williams Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, March 3rd were given a dividend of $0.79 per share. This is a boost from Sherwin-Williams’s previous quarterly dividend of $0.72. This represents a $3.16 annualized dividend and a yield of 0.93%. The ex-dividend date was Monday, March 3rd. Sherwin-Williams’s dividend payout ratio (DPR) is presently 29.95%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on SHW shares. Morgan Stanley decreased their target price on shares of Sherwin-Williams from $450.00 to $405.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Zelman & Associates raised shares of Sherwin-Williams to a “strong-buy” rating in a research note on Friday, January 17th. Royal Bank of Canada dropped their target price on Sherwin-Williams from $438.00 to $415.00 and set an “outperform” rating on the stock in a research report on Monday, February 3rd. Robert W. Baird set a $370.00 price target on Sherwin-Williams in a report on Friday, January 31st. Finally, Jefferies Financial Group reissued a “hold” rating and issued a $380.00 price objective (down from $423.00) on shares of Sherwin-Williams in a report on Monday, March 10th. One analyst has rated the stock with a sell rating, six have issued a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $401.13.

Check Out Our Latest Report on Sherwin-Williams

Sherwin-Williams Profile

(Free Report)

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.

Read More

Want to see what other hedge funds are holding SHW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Sherwin-Williams Company (NYSE:SHWFree Report).

Institutional Ownership by Quarter for Sherwin-Williams (NYSE:SHW)

Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.